We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Therapeutic Agent for Mustard Gas Injuries

By Biotechdaily staff writers
Posted on 17 Feb 2003
A post-injury agent for treating skin and eye injuries by mustard gas is being developed by Quick-Med Technologies, Inc. (Gainesville, FL, USA) in collaboration with the US Army.

Mustard gas, also called sulfur mustard, is one of the oldest chemical weapons. Threat assessment by the US Army considers sulfur mustard the most likely agent to be used by terrorists or foreign governments due to its low cost to produce, store, and dispense. Quick-Med has completed phase I and phase II clinical safety data studies for related ocular conditions and expects to acquire that data soon, as well as formulation analyses for the skin and eyes, and the results of efficacy experiments being conducted in laboratories in Israel and The Netherlands. The compound being used by Quick-Med is called Ilomastat.

"Quick-Med has an excellent opportunity to provide an important new drug to military and civil defense organizations worldwide. It will fill a major void in our preparedness against chemical and biologic attacks,” said Major General George Friel, a director of Quick-Med, who formerly headed the Nuclear, Chemical, and Biologic Defense Command for the US Army.





Related Links:
Quick-Med

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Clinical Informatics Platform
CLARION™
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
17 Feb 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
17 Feb 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
17 Feb 2003  |   BioResearch